In rare cases, children treated with recombinant growth hormone face a risk of obstructive and central sleep apnea, according to Missouri researchers.

Of 145 pediatric patients receiving growth hormone therapy at a St. Louis children's hospital, four developed sleep apnea despite having no history of sleep disorders.

Tonsils and adenoids in the four patients were normal size before GH treatment.

This content is only available via PDF.
You do not currently have access to this content.